Immunogenicity of vaccines for malaria-exposed populations

Immunogenicity of vaccines for malaria-exposed populations

<p>An efficacious malaria vaccine will be a necessary tool for malaria eradication, however current vaccine candidates have only demonstrated a moderate level of short-term efficacy. Additionally, these vaccines often display reduced immunogenicity and efficacy in the malaria-exposed target po...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Bowyer, GSA
Rannpháirtithe:	Hill, A
Formáid:	Tráchtas
Teanga:	English
Foilsithe / Cruthaithe:	2018
Ábhair:	Ebola Immunology Vaccines Malaria

Míreanna comhchosúla

Prospects for enhancing malaria vaccine efficacy by combining pre-erythrocytic antigens
de réir: Atcheson, E
Foilsithe / Cruthaithe: (2017)

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity
de réir: Valentina Agnolon, et al.
Foilsithe / Cruthaithe: (2020-11-01)

Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
de réir: de Cassan, S
Foilsithe / Cruthaithe: (2011)

The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen
de réir: Daniela Manno, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Persistence of immunological memory as a potential correlate of long-term, vaccine-induced protection against Ebola virus disease in humans
de réir: Chelsea McLean, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Investigating protective mechanisms of anti-sporozoite vaccines
de réir: Bellamy, DG
Foilsithe / Cruthaithe: (2023)

Towards functional antibody-based vaccines to prevent pre-erythrocytic malaria infection
de réir: Brandon Sack, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Ebola vaccine 2014: remained problems to be answered
de réir: Somsri Wiwanitkit, et al.
Foilsithe / Cruthaithe: (2015-02-01)

Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola
de réir: Jennifer K. Legardy-Williams, et al.
Foilsithe / Cruthaithe: (2020-03-01)

Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial
de réir: Julie A. Ake, et al.
Foilsithe / Cruthaithe: (2024-05-01)

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches)
de réir: Conall H. Watson, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Progress with new malaria vaccines
de réir: Webster Daniel, et al.
Foilsithe / Cruthaithe: (2003-01-01)

Insights into the design of an improved PfRH5 malaria immunogen using vaccine-induced monoclonal antibodies
de réir: Alanine, DGW
Foilsithe / Cruthaithe: (2017)

Ebola Virus Disease Vaccines: Development, Current Perspectives & Challenges
de réir: Sumira Malik, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions
de réir: Linda Bus-Jacobs, et al.
Foilsithe / Cruthaithe: (2024-04-01)

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia
de réir: I. V. Dolzhikova, et al.
Foilsithe / Cruthaithe: (2017-03-01)

Ebola vaccine uptake and attitudes among healthcare workers in North Kivu, Democratic Republic of the Congo, 2021
de réir: Reena H. Doshi, et al.
Foilsithe / Cruthaithe: (2023-07-01)

Malaria vaccine: A future hope to curtail the global malaria burden
de réir: Kaliyaperumal Karunamoorthi
Foilsithe / Cruthaithe: (2014-01-01)

Impact of Dietary Protein Restriction on the Immunogenicity and Efficacy of Whole-Sporozoite Malaria Vaccination
de réir: Helena Nunes-Cabaço, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Novel malaria vaccines
de réir: Matthew B. Laurens
Foilsithe / Cruthaithe: (2021-11-01)

Background malaria incidence and parasitemia during the three-dose RTS,S/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria
de réir: Griffin J Bell, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
de réir: Bauza, K
Foilsithe / Cruthaithe: (2012)

The Merits of Malaria Diagnostics during an Ebola Virus Disease Outbreak
de réir: Emmie de Wit, et al.
Foilsithe / Cruthaithe: (2016-02-01)

New approaches to pre-erythrocytic malaria vaccination
de réir: Mukhopadhyay, E
Foilsithe / Cruthaithe: (2021)

The Immunogenicity of a VLP-based Malaria Vaccine Targeting CSP in Pregnant and Neonatal Mice
de réir: Lucie Jelínková, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine
de réir: Brian Greenwood, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Modulation of receptor for advanced glycation end products signal transduction pathway as therapeutic option for malaria therapy
de réir: Chuah, Yaw Kuang
Foilsithe / Cruthaithe: (2015)

Humoral antimalaria immune response in Nigerian children exposed to helminth and malaria parasites
de réir: Selorme Adukpo, et al.
Foilsithe / Cruthaithe: (2022-09-01)

APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
de réir: Alberto L. García-Basteiro, et al.
Foilsithe / Cruthaithe: (2012-03-01)

APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
de réir: Alberto L. García-Basteiro, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Immunogenicity and safety of ebolavirus vaccines in healthy adults: a systematic review and meta-analysis of randomized controlled trials
de réir: Juntao Yin, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
de réir: Aroosa Younis Nadeem, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Malaria vaccine coverage estimation using age-eligible populations and service user denominators in Kenya
de réir: Angela K. Moturi, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Malaria vaccine–is it still required? Are vaccine alternatives enough to achieve malaria control?
de réir: Fsadni Claudia
Foilsithe / Cruthaithe: (2014-07-01)

Comparison between survival and severe models of malaria infection for better understanding of the underlying disease pathogenesis
de réir: Chong, Wing Chui
Foilsithe / Cruthaithe: (2013)

Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled Trial
de réir: Victorine A. Mensah, et al.
Foilsithe / Cruthaithe: (2017-11-01)

Adherence to Ebola-specific malaria case management guidelines at health facilities in Guinea during the West African Ebola epidemic
de réir: Ian Hennessee, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Health Precautions Taken by Travelers to Countries with Ebola Virus Disease
de réir: Ifeoma Ezeoke, et al.
Foilsithe / Cruthaithe: (2016-05-01)

Liver-stage vaccines for malaria
de réir: Longley, RJ
Foilsithe / Cruthaithe: (2013)

Malaria vaccine development: State of the art and beyond
de réir: Shuyang Guo, et al.
Foilsithe / Cruthaithe: (2021-01-01)